Funding profile · Consumer chronic and autoimmune care, India
Jeevam Health
An India-only cap table: $947,000 across four rounds from six named investors between 2020 and 2022, with no SEC filing anywhere in the picture. By late 2025 the company’s website had stopped resolving to Jeevam content.
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Aug 28, 2020 | Accelerator/Incubator, Y Combinator Summer 2020 | $150,000 | Y Combinator | PitchBook |
| Mar 23, 2021 | Pre-seed / Seed | Rs 1.8 crore, about $247,000 | Y Combinator and other investors, per company statement | ETHealthworld + PitchBook |
| May 14, 2021 | Early Stage VC | Not disclosed | Not named | PitchBook |
| Jul 6, 2022 | Early Stage VC | $550,000 | Not individually dated; investor list below | PitchBook |
| Undated | Full investor roster | Not applicable | Y Combinator, Goodwater Capital, Cloud Capital (India), Dexter Ventures, SRI Capital, Venture Garage | PitchBook |
What the filings show
No SEC Form D or other US securities filing for Jeevam Health was found. That is expected: Jeevam Health Private Limited is incorporated in India, under the Ministry of Corporate Affairs, not in the United States, and nothing in this research points to a US holding entity. What exists instead is the MCA’s own corporate record, which confirms the company’s incorporation but not its funding, since Indian private placements are not disclosed the way US Form D filings are.
Jeevam Health Private Limited · MCA incorporation record · filed Nov 2, 2020
- Registered
- Registrar of Companies, Delhi I
- Authorized capital
- Rs 100,000
- Paid up capital
- Rs 2,000
- Directors
- Kamran Alam (DIN 07629338); Piyush Kumar Vishwakarma (DIN 07629339)
- Latest AGM on file
- Sep 30, 2024
- Latest balance sheet on file
- Mar 31, 2024
- Status as filed
- Active, as of 2026
- Filing
- Ministry of Corporate Affairs, CIN U85300DL2020PTC372528
Reading the numbers
- The pre-seed figure checks out.ETHealthworld reported Rs 1.8 crore raised on Mar 23, 2021. At roughly 73 rupees to the dollar at that time, that converts to about $246,500, which lines up almost exactly with PitchBook’s $247,000 figure for a round dated the same day.
- The running total quietly absorbs the undisclosed round.PitchBook’s raised-to-date column reads $150,000 after the first round and $397,000 after the second, which is $150,000 plus $247,000 exactly. The company’s overall raised figure of $947,000 is $397,000 plus the $550,000 round from July 2022, again exactly. The undisclosed May 2021 round contributes nothing to either total, which means it was either a $0 close, folded into one of the other rounds, or simply a deal PitchBook could not size.
- Six investors, one accelerator.Of the six investors PitchBook lists, Y Combinator is the accelerator that opened the relationship in 2020. Goodwater Capital, Cloud Capital, Dexter Ventures, SRI Capital and Venture Garage are the venture and angel names attached to the later rounds, consistent with Dexter Ventures’ own account of investing in the company.
- No US paper trail.Every dollar in this profile is a data provider’s estimate or a press conversion of a rupee figure, not a primary securities filing. That is normal for a company that raised and operated entirely in India, but it means none of the amounts here carry the legal specificity of a Form D.
- The paid-up capital does not match the funding story.The MCA record shows just Rs 2,000 in paid up capital against Rs 100,000 authorized, figures typical of a private limited company’s founding paperwork. They do not reflect the roughly $947,000 in venture funding reported elsewhere, which is ordinary: Indian startups commonly route investor money through share premium and compulsorily convertible instruments that do not show up in the bare authorized or paid up capital fields.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Headcount | PitchBook lists 31 employees; LinkedIn’s range is 11 to 50. | Independent |
| Patients served | Company said about 12,000 patients as of 2022 press coverage, and separately claimed “50,000+ consultations” on its own site. | Company-stated |
| Product line | A subscription-style telemedicine and diet coaching service plus a branded thyroid supplement, marketed as “India’s first Multivitamin for Thyroid Health.” | Company-stated |
| Website status | jeevamhealth.com returned an HTTP 301 redirect to an unrelated tourism site in a Nov 28, 2025 Internet Archive capture, consistent with a lapsed domain rather than an operating company. | Public record |
| Founder status | Co-founder and CEO Piyush Vishwakarma’s public profile lists him as currently heading B2B products at Tata 1mg, with Jeevam Health as past work. | Independent |
| Corporate registry | MCA still lists Jeevam Health Private Limited as Active, with paperwork on file through Mar 2024. | Differs from operating status |
What to watch
- Whether the MCA record changes status, either to struck off or dormant, in a future annual filing cycle.
- Any statement from Vishwakarma, Alam or Musa about why the product stopped operating.
- Whether any of the named investors, Goodwater Capital, Cloud Capital, Dexter Ventures, SRI Capital or Venture Garage, write off or otherwise disclose the position.
The Jeevam Health story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- IndependentJeevam Health company and funding profile
- IndependentJeevam Health company profile and news item
- Public recordJeevam Health Private Limited, MCA corporate filing summary, CIN U85300DL2020PTC372528
- Public recordJeevam Health Private Limited company dashboard
- Public recordjeevamhealth.com, HTTP 301 redirect capture
- InvestorWhy We Invested in Jeevam Health
- CompanyJeevam Health company page
- CompanyJeevam Health (YC S20) company page
Compiled from Indian corporate registry records, published reports and third-party data providers as of September 25, 2026. Jeevam Health is incorporated in India and no SEC Form D or equivalent US filing was found for it. Healthcare Venture Capital Fund holds no position in Jeevam Health. This page is not an offer to sell or a recommendation to buy any security.
